10.09.2019
- Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...
10.09.2018
- Novartis has agreed to sell parts of its Sandoz US portfolio to Aurobindo Pharma USA as the Swiss drugmaker drives ahead with its strategy to focus on higher value medicines...
30.05.2018
- Sandoz, part of Swiss drugmaker Novartis, has won approval from the European Commission for its biosimilar Zessly (infliximab). The drug, which is a version of Janssen Biotech’s...
24.01.2018
- Sandoz, the generics subsidiary of Novartis, is collaborating with Biocon, an India-based biopharmaceuticals producer, to develop, manufacture and commercialize multiple...
15.07.2016
- AstraZeneca has filed a lawsuit to prevent the US Food and Drug Administration (FDA) from approving the sale of generic versions of Crestor, its multi-billion-dollar cholesterol...
21.06.2016
- Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to launch five biosimilars of major oncology and immunology biologics across key global markets by 2020...
04.04.2016
- Until recently, few outsiders would have called the agricultural chemicals sector exciting. It’s hard to imagine, for example, a thriller or torrid love story or even a poem set in...
25.02.2016
- In a transaction expected to close on Apr.1, Frankfurt, Germany-based private equity company International Chemical Investors Group (ICIG) has agreed with Swiss pharmaceutical...
